(CSE: NSHS | OTC: NSHSF) Based in Denver, Colorado, NanoSphere researches, develops and commercializes a diverse line of product formulations based on the patented NanoSphere Delivery System™ to meet the needs of healthcare providers, consumers and suppliers. The NanoSphere Delivery System™ is the first to apply nanotechnology to improve the bioavailability and efficacy of essential ingredients and medications. This disruptive technology introduces a significant advancement in these industries. NHS is the only nanotechnology company who plans to offer vertically integrated, commercial lines Our NanoSphere Delivery System™ is suited for intraoral, intranasal, peroral, and transdermal administration. The NanoSphere Health Science’s proprietary manufacturing process is rapid, scalable, and cost-efficient. For more information, please contact: info@nanospherehealth.com